Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Corcept Therapeutics Initiates Phase 1b Trial of Relacorilant Plus Pembrolizumab in Patients with Adrenal Cancer with Cortisol Excess


Benzinga | Mar 15, 2021 07:30AM EDT

Corcept Therapeutics Initiates Phase 1b Trial of Relacorilant Plus Pembrolizumab in Patients with Adrenal Cancer with Cortisol Excess






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC